First Houston Capital’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-28,600
Closed -$1.77M 68
2015
Q4
$1.77M Sell
28,600
-5,150
-15% -$325K 1.61% 30
2015
Q3
$2.13M Buy
33,750
+4,158
+14% +$297K 2.01% 22
2015
Q2
$1.94M Hold
29,592
1.73% 31
2015
Q1
$1.94M Buy
29,592
+1,292
+5% +$85.9K 1.69% 31
2014
Q4
$1.84M Buy
28,300
+3,100
+12% +$200K 1.63% 28
2014
Q3
$1.51M Sell
25,200
-4,800
-16% -$314K 1.42% 38
2014
Q2
$2.08M Buy
30,000
+300
+1% +$19.4K 1.99% 29
2014
Q1
$1.94M Sell
29,700
-5,000
-14% -$325K 1.9% 34
2013
Q4
$2.15M Buy
34,700
+21,200
+157% +$1.23M 2.11% 28
2013
Q3
$724K Buy
+13,500
New +$695K 0.78% 43

Other funds holding STJ

First Houston Capital's STJ Position: Q1 2016 in Review

First Houston Capital sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 28,600 shares — an estimated $1.77M sold.

First Houston Capital first reported a position in STJ in Q3 2013 and held it in 10 quarters. The position peaked at $2.15M in Q4 2013. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • First Houston Capital reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • First Houston Capital sold 28,600 St Jude Medical shares in Q1 2016, an estimated $1.77M.
  • First Houston Capital first reported a position in St Jude Medical in Q3 2013 and held it in 10 quarters.
  • First Houston Capital's St Jude Medical position peaked at $2.15M in Q4 2013.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on First Houston Capital's 13F filing for Q1 2016, filed 16 May 2016.